April « 2012 « Return On Focus --- http://returnonfocus.com --- Return On Focus

Messaging Beyond Your Brand Detail Aid

April 29, 2012

Fitness Trainers and Pharma — an Exercise in Brand Positioning

Filed under: Marketing Effectiveness,What We Think — dreinhardt @ 10:53 pm

I recently came across an illustration of the right way to go about developing a focused and differentiated positioning from a very unlikely source – a trainer at my local gym, YMCA.

Fitness Trainers are relatively undifferentiated in today’s world and most compete on little more than price. Typically, it’s the conditioning of the trainer that serves as a key indicator of their skill and success.

But the other day I watched a trainer at my gym illustrate her services by going through a series of sophisticated positioning progressions with a potential client that helped to crystallize her single-minded positioning in our local area.

  1. Certified Fitness Trainer – everyone has some sort of qualifications that few consumers can decipher and/or appreciate
  2. Female, Certified Fitness Trainer – while once unique, females make up at least half of the trainers now
  3. Female, Certified Fitness Trainer, Focused Exclusively on Women – not unique enough since the dynamics of the market generally lend themselves to women wanting to train with female trainers
  4. Pre-Wedding Fitness TrainingCertified Fitness Trainer, Focused Exclusively on Helping Women Get Ready for their Wedding Day – differentiated and focused around an event that helped to establish a stand-out positioning within both the gym and the community

What this fitness trainer settled in on is a User-Based positioning, which according to the marketing literature and our research is one of the most powerful genres of positioning.

How was she able to get there while most biotechnology and pharmaceutical positioning development projects are mired in attribute and benefits-based positioning genres? She understood that positioning helps her establish a beachhead of clientele from which she could broaden her brand without niching herself in the process.
So, how has her beachhead played out?

  • Most of the brides, pleased with the results, stayed on well after their wedding day
  • Focused-positioning aligned to a specific event resonated with initial customers and encouraged them to share with other friends within the engagement age cohort
  • Demonstrated results with young brides resulted in her making clients of some of their Grooms who were motivated to keep pace with their future/new wives

The beauty of this illustration is that it simply and effectively highlights the core philosophies of good positioning. I never did finish that workout . . .

TwitterLinkedInFacebookPinterestGoogle ReaderShare

April 22, 2012

Shoot for Right Time Data, Not Real Time Data

Filed under: Marketing Effectiveness,What We Think — dreinhardt @ 11:23 pm

The title of today’s post comes directly from Avinash Kaushik’s Occam’s Razor post A Big Data Imperative: Driving Big Action. Avinash’s blog is a must read for anyone who believes that analytics matter regardless of industry. A salient point that he makes is that with the shear volume of information marketers now have, “it is so much more important to be magnificent at knowing what to ignore.”

At ROF, we couldn’t agree more. In fact, an ROF analysis done a few years back showed that the average Pharmaceutical/Biotechnology Product Manager was getting 6 weekly reports and more than a dozen monthly reports coming from a variety of internal functional partners and external tactical partners. The frequency and volume only increased as we examined the Director level.

Pharmaceutical marketers are drowning in data and are likely having trouble determining what to ignore. It’s time to take a step back and proactively determine when is the ‘right time’ for specific data and the corresponding marketing insights.

It’s likely different for every brand, but here are some ‘right time data’ catalysts to consider based on the average brand calendar:

  • National Sales Meeting – update on the brand status and to review the yardstick for the upcoming year
  • Situation Analysis – kick off business planning right with the latest salient points
  • Tactical Plan Development – updated stats on the performance of current investments helps to strengthen the recommendations for the following year
  • Launch Readiness Review – in most companies these meetings are scheduled well in advance, so right time data can be used to increase the level of comfort or discomfort with the plan

Lastly, think about the times in the year when additional funding usually becomes available or when funding cuts happen. Right time data could be the difference between keeping or losing that key investment!

TwitterLinkedInFacebookPinterestGoogle ReaderShare

April 15, 2012

The New Normal – Express Launch and What to Do About It

For a variety of reasons, it seems that the new normal for biotechnology and pharmaceutical product launches is an expressed timeline. By ‘expressed,’ I mean less than 12 months from full marketing funding to product approval. Having been involved in at least 3 expressed launches in the past 18 months, one thing is clear –most internal and external stakeholders are comfortable investing in and generating a significant volume of tactics even in the absence of a defined strategy!

The pressure to do something is significant and the need for each stakeholder to demonstrate activity is high. But without a strategy, how do you know you’re selecting the right tactics and programs to maximize your brand uptake? The best practice that I’ve seen recently is the development of a succinct strategic road map, illustrated below:

Strategic Roadmap

In order to overcome this common pitfall with, we assembled both internal and external stakeholders at the initial launch readiness review meeting and worked through a draft of a strategic road map like the one above. This process enabled the entire team to:

  • Clearly elucidate the necessary strategic steps to own the desired launch communication platform (i.e., brand positioning + message hierarchy)
  • Understand the sequencing of actions, along with the associated dependencies and mandatories for success
  • Gain agreement upon the key metrics – leading and lagging indictors – to distribute accountability to all the stakeholders and not just the Brand Team

With the reality of a fast-approaching approval on everyone’s minds, the meeting was tense at times, but the outcome provided everyone an objective touchstone to guide tactical investments and ensure focus.

Are you waiting on Phase III data or an impending acquisition or co-marketing agreement for a Phase III product? Proactive planning for the ‘expressed’ launch could be the key to your success. Call us and pick our brains. The Strategic Roadmap might just become your “new normal.”

TwitterLinkedInFacebookPinterestGoogle ReaderShare

April 8, 2012

Messaging Beyond Your Brand Detail Aid

I believe the core construct for developing and testing brand messaging in the pharmaceutical industry is in need of a major update.

Why do I say that? Well, for starters I keep seeing the same process that was being implemented 15 years ago still being used. You may think, if it’s not broken, don’t fix it. Right? Well, let’s think a bit more about whether it’s truly “not broken”.

What is the traditional industry approach? Agencies develop buckets of messages broken up into typical categories—efficacy, safety, mechanism, dosing, etc. decoupled from the brand positioning. These messages are then tested in a similar fashion with physicians selecting their preferred message(s) in each category. The whole point of this exercise is to determine the messages that should be included in each section of the Brand Detail Aid.

This process is flawed on a number of levels, but perhaps one of the most significant is the fact that it is completely biased toward the detail aid. Because it does not result in a centralized brand story but rather a series of messages that are then amalgamated into a detail aid, marketing teams are often left with a void when it comes time to determine the messages that should be included in other promotional initiatives such as websites, journal ads, etc.

The other problem is that this process typically results in an excessively long detail piece that is rarely used during the average 2-minute rep call. The overriding, concise brand story is sacrificed.
So, what’s my idea to improve this process? Do not de-couple positioning and messaging research. By testing them together, you can be confident that you are optimizing the resulting communication framework for your product across all marketing channels.

The key lies in developing and validating a Brand Communication Platform and to ensure that it includes a core statement that reflects your brand positioning and supportive messaging that forms a compelling story designed to motivate prescribing.

With detail aids being utilized less and less by reps and the utility suspect among doctors, isn’t it time that a new foundation for your brand’s communication be explored?

TwitterLinkedInFacebookPinterestGoogle ReaderShare
Follow us on
Pinterest Twitter slideshare
Contact Us
XXX
YYY

Powered by WordPress